MEDI HYDRO DP VITA C AMPOULE niacinamideadenosine liquid

País: Estados Unidos

Idioma: inglés

Fuente: NLM (National Library of Medicine)

Cómpralo ahora

Ficha técnica Ficha técnica (SPC)
13-05-2018

Ingredientes activos:

NIACINAMIDE (UNII: 25X51I8RD4) (NIACINAMIDE - UNII:25X51I8RD4)

Disponible desde:

MBG Inc (Korea Institute of Science Development)

Designación común internacional (DCI):

NIACINAMIDE

Composición:

NIACINAMIDE 0.02 mg in 100 mL

tipo de receta:

OTC DRUG

Estado de Autorización:

unapproved drug other

Ficha técnica

                                MEDI HYDRO DP VITA C AMPOULE- NIACINAMIDE,ADENOSINE LIQUID
MBG INC (KOREA INSTITUTE OF SCIENCE DEVELOPMENT)
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this labeling has not been_
_approved by FDA. For further information about unapproved drugs,
click here._
----------
MEDI HYDRO DP VITA C AMPOULE
Do not use this product if you have allergy
Keep out of reach of children.
Active Ingredients Purposes
Niacinamide
Adenosine
THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE. SEE
FULL PRESCRIBING INFORMATION
FOR MEDI HYDRO DP VITA C AMPOULE
Apply twice a day.
_WARNINGS:_
For external use only
Do not use on damaged or broken skin.
Keep out of eyes. Rinse with water to remove.
Ask a doctor if rash occurs.
Skin conditioning
_INACTIVE INGREDIENTS:_
Water
MEDI HYDRO DP VITA C AMPOULE
MEDI HYDRO DP VITA C AMPOULE
niacinamide,adenosine liquid
PRODUCT INFORMATION
PRODUCT T YPE
HUMAN OTC DRUG
ITE M CODE (SOURCE )
NDC:70 6 9 4-0 0 9 0
ROUTE OF ADMINISTRATION
TOPICAL
ACTIVE INGREDIENT/ACTIVE MOIETY
INGREDIENT NAME
BASIS OF STRENGTH
STRE NG TH
NIACINAMIDE (UNII: 25X51I8 RD4) (NIACINAMIDE - UNII:25X51I8 RD4)
NIACINAMIDE
0 .0 2 mg in 10 0 mL
ADENO SINE (UNII: K72T3FS56 7) (ADENOSINE - UNII:K72T3FS56 7)
ADENOSINE
0 .0 0 4 mg in 10 0 mL
INACTIVE INGREDIENTS
INGREDIENT NAME
STRE NG TH
WATER (UNII: 0 59 QF0 KO0 R)
PACKAG ING
#
ITEM CODE
PACKAGE DESCRIPTION
MARKETING START DATE
MARKETING END DATE
1
NDC:70 6 9 4-0 0 9 0 -1 30 mL in 1 BOTTLE; Type 0 : No t a Co mbinatio
n Pro duct
0 8 /15/20 17
0 8 /15/20 18
MARKETING INFORMATION
MBG Inc (Korea Institute of Science Development)
MARKE TING CATE GORY
APPLICATION NUMBE R OR MONOGRAPH CITATION
MARKE TING START DATE
MARKE TING END DATE
unappro ved drug o ther
0 8 /15/20 17
0 8 /15/20 18
LABELER -
MBG Inc (Korea Institute of Science Development) (688436167)
ESTABLISHMENT
NAME
AD D RE S S
ID/FEI
BUSINE SS OPE RATIONS
MBG Inc (Ko rea Institute o f Science Develo pment)
6 8 8 436 16 7
ma nufa c ture (70 6 9 4-0 0 9 0 )
Revised: 8/2017
                                
                                Leer el documento completo
                                
                            

Buscar alertas relacionadas con este producto